Scientists and companies are exploring the idea of manufacturing drugs in space. A new partnership between a space startup and a major pharmaceutical firm is taking this concept from science fiction to reality. The goal is to produce new drug molecules in orbit, where the unique conditions could lead to better or even entirely new medicines.

The Science of Space-Based Drug Production

Manufacturing in space is based on the idea that microgravity changes how chemicals behave. Without gravity, liquids form spheres, and crystals grow differently than on Earth. This can help create drugs with more stable structures or improved properties. The hope is that drugs made in orbit might be more effective or last longer, opening new possibilities for treating diseases.

To test this, companies launch drug samples into orbit, where they are allowed to crystallize in microgravity. Once formed, these crystals can be studied for differences compared to those made on Earth. The process involves sending the drugs into space, letting them form, and then returning the resulting materials to Earth for analysis.

Commercial Space Manufacturing Takes a Step Forward

This effort marks a significant shift from government-led experiments to commercial ventures. A startup called Varda Space Industries is now offering to produce materials in orbit on a regular basis. They’ve partnered with United Therapeutics, a biotech company known for treatments for lung diseases. The partnership aims to test whether space-made drugs can be better or different from traditional ones.

Varda has been using rockets from SpaceX to send small satellites and experiment capsules into orbit. These capsules can detach from the main satellite, re-enter Earth’s atmosphere at hypersonic speeds, and land in remote areas like Australia. Some of their missions also serve military research, with dual-use technology that benefits both commercial and defense projects.

The company’s founders believe that as rocket launches become more frequent and cheaper, space manufacturing will become more practical. They see space as a new frontier for producing valuable products, including drugs, which can be very profitable due to their high value per weight. This approach could revolutionize how we create and develop medicines in the future.

While space manufacturing is still in its early stages, the industry is making progress. High-profile figures like Jeff Bezos have suggested moving heavy industry into space to reduce pollution on Earth. However, the high costs of launching materials remain a big obstacle. Currently, it costs about $7,000 to send just one kilogram into orbit, making many industrial processes too expensive to do in space.

Despite this, drugs are a promising exception. They tend to be high-value products, meaning the cost of launching them can be justified if the results are beneficial. Producing drugs in space could lead to more stable or effective medicines, which could be worth the investment. This innovative approach might open up new pathways in pharmaceutical research and development.

Overall, the push to manufacture drugs in orbit is still in its early days but shows promising signs. As technology advances and launch costs decrease, space could become a new factory for medicines and other high-value materials. This could change the future of medicine, making treatments safer, more effective, and possibly even more affordable in the long run.

Inspired by

• https://www.technologyreview.com/2026/05/13/1137153/varda-united-therapeutics-drug-manufacturing-in-space/

Sources

• ms.now
• nature.com
• nasa.gov